{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:17:43Z","timestamp":1789823863899,"version":"4.0.1"},"reference-count":64,"publisher":"Global Edge Printers and Publishers","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Carcinog"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/jcar.jcar_24_20","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T10:25:19Z","timestamp":1628763919000},"page":"9","source":"Crossref","is-referenced-by-count":28,"title":["Understanding the molecular mechanism associated with reversal of oral submucous fibrosis targeting hydroxylysine aldehyde-derived collagen cross-links"],"prefix":"10.66838","volume":"20","author":[{"given":"Raghu","family":"Radhakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SmithaSammith","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShamaPrasada","family":"Kabekkodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NV","family":"Anil Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapaettu","family":"Satyamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56529","reference":[{"key":"key-10.4103\/1477-3163.323799-1","first-page":"60","article-title":"The type of collagen cross-link determines the reversibility of experimental skin fibrosis","author":"van","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/1477-3163.323799-2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0714.1999.tb02033.x","article-title":"The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma","author":"Trivedy","year":"1999","journal-title":"J Oral Pathol Med"},{"key":"key-10.4103\/1477-3163.323799-3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0714.2005.00325.x","article-title":"Molecular pathogenesis of oral submucous fibrosis \u2013 A collagen metabolic disorder","author":"Rajalalitha","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"key-10.4103\/1477-3163.323799-4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/CEJ.0000000000000575","article-title":"A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis","author":"Phulari","year":"2020","journal-title":"Eur J Cancer Prev"},{"key":"key-10.4103\/1477-3163.323799-5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oooo.2015.12.018","article-title":"Oral submucous fibrosis: Review on mechanisms of malignant transformation","author":"Ekanayaka","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"key-10.4103\/1477-3163.323799-6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1574892813666180227103147","article-title":"Oral submucous fibrosis as an overhealing wound: Implications in malignant transformation","author":"Sharma","year":"2018","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"key-10.4103\/1477-3163.323799-7","first-page":"377","article-title":"Collagen cross-linking mediated by lysyl hydroxylase 2: An enzymatic battlefield to combat fibrosis","author":"Piersma","year":"2019","journal-title":"Essays Biochem"},{"key":"key-10.4103\/1477-3163.323799-8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.31236","article-title":"Lysyl oxidase (LOX) family members: Rationale and their potential as therapeutic targets for liver fibrosis","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"key-10.4103\/1477-3163.323799-9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/10409238.2016.1269716","article-title":"Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease","author":"Gjaltema","year":"2017","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"key-10.4103\/1477-3163.323799-10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","article-title":"Collagens \u2013 Structure, function, and biosynthesis","author":"Gelse","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"key-10.4103\/1477-3163.323799-11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1146\/annurev.bi.53.070184.003441","article-title":"Cross-linking in collagen and elastin","author":"Eyre","year":"1984","journal-title":"Annu Rev Biochem"},{"key":"key-10.4103\/1477-3163.323799-12","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1096\/fasebj.6.7.1348714","article-title":"Enzymatic and nonenzymatic cross-linking of collagen and elastin","author":"Reiser","year":"1992","journal-title":"FASEB J"},{"key":"key-10.4103\/1477-3163.323799-13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.0022-202x.2001.01414.x","article-title":"Different pattern of collagen cross-links in two sclerotic skin diseases: Lipodermatosclerosis and circumscribed scleroderma","author":"Brinckmann","year":"2001","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/1477-3163.323799-14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02869896","article-title":"The mechanisms and consequences of the maturation and ageing of collagen","author":"Bailey","year":"1999","journal-title":"Proc Indian Acad Sci"},{"key":"key-10.4103\/1477-3163.323799-15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/ajcn\/31.7.1221","article-title":"Cross-linking amino acids in collagen and elastin","author":"Rucker","year":"1978","journal-title":"Am J Clin Nutr"},{"key":"key-10.4103\/1477-3163.323799-16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI74725","article-title":"Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma","author":"Chen","year":"2015","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1477-3163.323799-17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2230.2001.00886.x","article-title":"Evidence for increased pyridinoline concentration in fibrotic tissues in diffuse systemic sclerosis","author":"Istok","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/1477-3163.323799-18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840150408","article-title":"Hydroxypyridinium collagen cross-links in human liver fibrosis: Study of alveolar echinococcosis","author":"Ricard-Blum","year":"1992","journal-title":"Hepatology"},{"key":"key-10.4103\/1477-3163.323799-19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1042\/bj1810639","article-title":"Native cross-links in collagen fibrils induce resistance to human synovial collagenase","author":"Vater","year":"1979","journal-title":"Biochem J"},{"key":"key-10.4103\/1477-3163.323799-20","doi-asserted-by":"crossref","first-page":"39027","DOI":"10.1074\/jbc.M006700200","article-title":"Effect of collagen turnover on the accumulation of advanced glycation end products","author":"Verzijl","year":"2000","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1477-3163.323799-21","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/ki.1997.455","article-title":"Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility","author":"Mott","year":"1997","journal-title":"Kidney Int"},{"key":"key-10.4103\/1477-3163.323799-22","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.12659\/MSM.910761","article-title":"Lysyl hydroxylase inhibition by minoxidil blocks collagen deposition and prevents pulmonary fibrosis via TGF- \u03b2 1\/Smad3 signaling pathway","author":"Shao","year":"2018","journal-title":"Med Sci Monit"},{"key":"key-10.4103\/1477-3163.323799-23","first-page":"95","article-title":"Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels","author":"van","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/1477-3163.323799-24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1523-1747.1999.00735.x","article-title":"Overhydroxylation of lysyl residues is the initial step for altered collagen cross-links and fibril architecture in fibrotic skin","author":"Brinckmann","year":"1999","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/1477-3163.323799-25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0005-2795(73)90272-9","article-title":"Changes in the nature of the collagen during development and resorption of granulation tissue","author":"Bailey","year":"1973","journal-title":"BBA Protein Struct"},{"key":"key-10.4103\/1477-3163.323799-26","doi-asserted-by":"crossref","first-page":"18892","DOI":"10.1073\/pnas.1004952107","article-title":"LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling","author":"Gao","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/1477-3163.323799-27","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1158\/0008-5472.CAN-16-3152","article-title":"Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer","author":"Salvador","year":"2017","journal-title":"Cancer Res"},{"key":"key-10.4103\/1477-3163.323799-28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1172\/JCI93554","article-title":"The fibrotic tumor stroma","author":"Yamauchi","year":"2018","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1477-3163.323799-29","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","article-title":"LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis","author":"Cox","year":"2013","journal-title":"Cancer Res"},{"key":"key-10.4103\/1477-3163.323799-30","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3892\/ijo.2013.1878","article-title":"Hypoxia inducible factor 1\u03b1-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer","author":"Ji","year":"2013","journal-title":"Int J Oncol"},{"key":"key-10.4103\/1477-3163.323799-31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08977194.2011.582839","article-title":"Role of TGF-\u03b2 and BMP7 in the pathogenesis of oral submucous fibrosis","author":"Khan","year":"2011","journal-title":"Growth Factors"},{"key":"key-10.4103\/1477-3163.323799-32","doi-asserted-by":"crossref","first-page":"e51806","DOI":"10.1371\/journal.pone.0051806","article-title":"Activation of TGF-\u03b2 pathway by areca nut constituents: A possible cause of oral submucous fibrosis","author":"Khan","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/1477-3163.323799-33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0973-029X.140751","article-title":"Molecular screening of lysyl oxidase G473A polymorphism in oral submucous fibrosis","author":"Thorawat","year":"2014","journal-title":"J Oral Maxillofac Pathol","ISSN":"https:\/\/id.crossref.org\/issn\/0973-029X","issn-type":"print"},{"key":"key-10.4103\/1477-3163.323799-34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1034\/j.1600-0714.2000.290601.x","article-title":"Raised tissue copper levels in oral submucous fibrosis","author":"Trivedy","year":"2000","journal-title":"J Oral Pathol Med"},{"key":"key-10.4103\/1477-3163.323799-35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0714.1995.tb01210.x","article-title":"Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan","author":"Ma","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"key-10.4103\/1477-3163.323799-36","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1158\/1078-0432.CCR-06-2685","article-title":"Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis","author":"Shieh","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/1477-3163.323799-37","first-page":"360","article-title":"Recognition of lysyl oxidase as a potential predictive biomarker for oral squamous cell carcinoma: An immunohistochemical study","author":"Bhanu","year":"2020","journal-title":"Minerva Stomatol"},{"key":"key-10.4103\/1477-3163.323799-38","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1002\/jcb.28669","article-title":"Upregulated LOX and increased collagen content associated with aggressive clinicopathological features and unfavorable outcome in oral squamous cell carcinoma","author":"Yu","year":"2019","journal-title":"J Cell Biochem"},{"key":"key-10.4103\/1477-3163.323799-39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0022034519828710","article-title":"Aberrant collagen cross-linking in human oral squamous cell carcinoma","author":"Saito","year":"2019","journal-title":"J Dent Res"},{"key":"key-10.4103\/1477-3163.323799-40","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1096\/fj.14-268425","article-title":"Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice","author":"Liu","year":"2016","journal-title":"FASEB J"},{"key":"key-10.4103\/1477-3163.323799-41","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","author":"Ikenaga","year":"2017","journal-title":"Gut"},{"key":"key-10.4103\/1477-3163.323799-42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bbadis.2018.01.019","article-title":"Molecular basis of disease inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking","author":"Zhao","year":"2018","journal-title":"BBA Mol Basis Dis"},{"key":"key-10.4103\/1477-3163.323799-43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/bjh.14501","article-title":"A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis","author":"Verstovsek","year":"2017","journal-title":"Br J Haematol"},{"key":"key-10.4103\/1477-3163.323799-44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: A randomised, double-blind, controlled, phase 2 trial","author":"Raghu","year":"2017","journal-title":"Lancet Respir Med"},{"key":"key-10.4103\/1477-3163.323799-45","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/liv.13177","article-title":"Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: Results of a 6-month open-label safety trial","author":"Meissner","year":"2016","journal-title":"Liver Int"},{"key":"key-10.4103\/1477-3163.323799-46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1634\/theoncologist.2017-0024","article-title":"A Phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma","author":"Benson","year":"2017","journal-title":"Oncologist"},{"key":"key-10.4103\/1477-3163.323799-47","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","author":"Harrison","year":"2018","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1477-3163.323799-48","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hep.30237","article-title":"Simtuzumab for primary sclerosing cholangitis: Phase 2 study results with insights on the natural history of the disease","author":"Muir","year":"2019","journal-title":"Hepatology"},{"key":"key-10.4103\/1477-3163.323799-49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1634\/theoncologist.2016-0479","article-title":"A phase II, randomized, double-blind, placebo-controlled study of simtuzumab in combination with FOLFIRI for the second-line treatment of metastatic KRAS mutant colorectal adenocarcinoma","author":"Hecht","year":"2017","journal-title":"Oncologist"},{"key":"key-10.4103\/1477-3163.323799-50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment","author":"Barry-Hamilton","year":"2010","journal-title":"Nat Med"},{"key":"key-10.4103\/1477-3163.323799-51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0046-8177(91)90287-Y","article-title":"Sequential histopathologic alterations in Indian childhood cirrhosis treated with d-penicillamine","author":"Bhusnurmath","year":"1991","journal-title":"Hum Pathol"},{"key":"key-10.4103\/1477-3163.323799-52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00005176-199501000-00006","article-title":"Reversal of Indian Childhood cirrhosis by D-pencillamine therapy","author":"Pradhan","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1477-3163.323799-53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.114.2.507","article-title":"Colchicine, D-pencillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: A controlled clinical trial","author":"Selman","year":"1998","journal-title":"Chest"},{"key":"key-10.4103\/1477-3163.323799-54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cpt196784593","article-title":"Studies on beta-aminopropionitrile in patients with scleroderma","author":"Keiser","year":"1967","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/1477-3163.323799-55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mlc.2003.20","article-title":"Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice","author":"Brewer","year":"2003","journal-title":"J Lab Clin Med"},{"key":"key-10.4103\/1477-3163.323799-56","doi-asserted-by":"crossref","first-page":"153S","DOI":"10.1378\/chest.89.3_Supplement.153S","article-title":"D-penicillamine prevents collagen accumulation in lungs of rats given bleomycin","author":"Geismar","year":"1986","journal-title":"Chest"},{"key":"key-10.4103\/1477-3163.323799-57","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.bmcl.2018.07.001","article-title":"Inhibition of the LOX enzyme family members with old and new ligands.Selectivity analysis revisited","author":"Hajd\u00fa","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"key-10.4103\/1477-3163.323799-58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajpath.2014.11.009","article-title":"Disruption of collagen homeostasis can reverse established age-related myocardial fibrosis","author":"Rosin","year":"2015","journal-title":"Am J Pathol"},{"key":"key-10.4103\/1477-3163.323799-59","doi-asserted-by":"crossref","first-page":"e0183013","DOI":"10.1371\/journal.pone.0183013","article-title":"Targeting lysyl oxidase reduces peritoneal fibrosis","author":"Harlow","year":"2017","journal-title":"PLoS One"},{"key":"key-10.4103\/1477-3163.323799-60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0006-291X(03)01262-2","article-title":"Identification, expression, and tissue distribution of the three rat lysyl hydroxylase isoforms","author":"Mercer","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/1477-3163.323799-61","first-page":"40967","article-title":"Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis","author":"van","year":"2003","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1477-3163.323799-62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj2830051","article-title":"Minoxidil specifically decreases the expression of lysine hydroxylase in cultured human skin fibroblasts","author":"Hautala","year":"1992","journal-title":"Biochem J"},{"key":"key-10.4103\/1477-3163.323799-63","doi-asserted-by":"crossref","first-page":"1900119","DOI":"10.1002\/adtp.201900119","article-title":"Lysyl Oxidase Like-2 (LOXL2): An emerging oncology target","author":"Chopra","year":"2020","journal-title":"Adv Ther"},{"key":"key-10.4103\/1477-3163.323799-64","first-page":"1194","article-title":"High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.Arthritis Rheum","author":"Clements","year":"1999","journal-title":""}],"container-title":["Journal of Carcinogenesis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:43:52Z","timestamp":1777661032000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.carcinogenesis.com\/text.asp?2021\/20\/1\/9\/323799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["323799"],"URL":"https:\/\/doi.org\/10.4103\/jcar.jcar_24_20","relation":{},"ISSN":["1477-3163"],"issn-type":[{"value":"1477-3163","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}